… Our patient was diagnosed with chronic myeloid leukemia (CML) in chronic phase (CP)
when he was 40 years old. Although dasatinib (DAS) was prescribed during his clinical course, …

… therapy. Results appear independent of both dose reduction and potential pretreatment with
interferon-α… of chronic myeloid leukemia (CML). Currently, the life expectancy of patients in …

… Chronic myeloid leukemia is a clonal myeloproliferative disorder in which the characteristic
reciprocal translocation, t(9;22)(q34;q11) forms the Philadelphia chromosome and leads to …

… Chronic myeloid leukemia (CML) is a neoplastic disease … important roles in prognosis and
treatment strategies. Philadelphia (Ph… CML: chronic myeloid leukemia; INF-α: interferon-α; TKI: …

… 400mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly
diagnosed chronic phase chronic myeloid leukaemia. Br J Haematol 2014; 164: 223–232. …

… Imatinib has revolutionized the treatment and prognosis of chronic myeloid leukemia (CML)
with survival rates now approaching those of the age-matched healthy population. To be …

… (CML) that developed after successful treatment of … therapy with hydroxyurea, interferon-α
and arsenic trioxide. We propose that optimization of chemotherapy regimen and treatment …

… Immunotherapy with interferon-α (IFN-α) shows some biological effects, although further
research is needed for optimal application in enhancing discontinuation rates. Other …

… chronic phase chronic myeloid leukemia. Most models had a Markov structure, a 1 year to
lifetime time horizon, and a 1-month cycle length. Commonly assessed treatments … interferon-α…

… Chronic myeloid leukemia (CML) is a clonal disorder of multipotent hematopoietic progenitor
cells and is characterized by t (9; 22) (q34; q11) that produce the BCR-ABL fusion protein …